A
Anu Suomalainen
Researcher at University of Helsinki
Publications - 214
Citations - 19456
Anu Suomalainen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Mitochondrial DNA & Mitochondrial disease. The author has an hindex of 67, co-authored 206 publications receiving 17041 citations. Previous affiliations of Anu Suomalainen include Montreal Neurological Institute and Hospital & University of Eastern Finland.
Papers
More filters
Journal ArticleDOI
Quantitative analysis of human DNA sequences by PCR and solid-phase minisequencing.
TL;DR: In this paper, a solid-phase minisequencing method based on competetive PCR is proposed for DNA quantification, which can be applied to determination of allele frequencies in pooled DNA samples, of mitochondrial heteroplasmy, of gene copy numbers and to forensic DNA analysis.
Journal ArticleDOI
Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts.
Ras Trokovic,Jere Weltner,Tuula Manninen,Milla Mikkola,Karolina Lundin,Riikka H. Hämäläinen,Anu Suomalainen,Timo Otonkoski +7 more
TL;DR: It is shown that stable iPSC lines can be generated from human myoblasts at efficiency similar to that of fibroblasts when appropriate media is used, and the efficiency of the feeder-free iPSCs generation can be significantly improved by inhibitors of histone deacetylase (sodium butyrate) and TGF-β signaling.
Journal ArticleDOI
Analysis of the trinucleotide CAG repeat from the human mitochondrial DNA polymerase gene in healthy and diseased individuals.
Anja T. Rovio,Valeria Tiranti,Amy L Bednarz,Anu Suomalainen,Johannes N. Spelbrink,Nicolas Lecrenier,Atle Melberg,Massimo Zeviani,Joanna Poulton,Françoise Foury,Howard T. Jacobs,Howard T. Jacobs +11 more
TL;DR: Patients with a variety of molecular lesions in mtDNA, including sporadic, clonal deletions, maternally inherited point mutations, autosomally transmitted mtDNA depletion and autosomal dominant multiple deletions showed no differences in POLG trinucleotide repeat-length distribution from controls, ruling out POLG repeat expansion as a common pathogenic mechanism in disorders characterised by mitochondrial genome instability.
Journal ArticleDOI
Therapy for mitochondrial disorders: little proof, high research activity, some promise.
Anu Suomalainen,Anu Suomalainen +1 more
TL;DR: This work reviews strategies that have been tested or that can be proposed to be feasible as intervention for mitochondrial disease and aims to slow down the disease progression or are palliative in nature.
Journal ArticleDOI
Mitochondrial DNA and disease.
TL;DR: Although no breakthroughs in the therapeutic trials on the devastating mitochondrial diseases have so far been achieved, detection of mtDNA mutations offers an accurate diagnosis and is a prerequisite for genetic counselling, being now accessible to most clinicians.